High density lipoprotein: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 14: Line 14:


== Treatment ==
== Treatment ==
[[High density lipoprotein landmark trials|Landmark Trials]] | [[High density lipoprotein medical therapy|Medical Therapy]] | [[High density lipoprotein primary prevention|Primary Prevention]] | [[High density lipoprotein secondary prevention|Secondary Prevention]] | [[High density lipoprotein cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[High density lipoprotein future or investigational therapies|Future or Investigational Therapies]]
[[High density lipoprotein landmark trials|Landmark Trials]] | [[High density lipoprotein secondary prevention|Secondary Prevention]] | [[High density lipoprotein cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[High density lipoprotein future or investigational therapies|Future or Investigational Therapies]]


==Related Chapters==
==Related Chapters==

Revision as of 19:56, 26 April 2013

High Density Lipoprotein Microchapters

Home

Patient information

Overview

Historical Perspective

Classification

Physiology

Pathophysiology

Causes

Low HDL
High HDL

Epidemiology and Demographics

Screening

Natural History, Complications and Prognosis

Diagnosis

HDL Laboratory Test

Treatment

Medical Therapy

Prevention

Future or Investigational Therapies

Clinical Trials

Landmark Trials

List of All Trials

Case Studies

Case #1

High density lipoprotein On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of High density lipoprotein

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on High density lipoprotein

CDC on High density lipoprotein

High density lipoprotein in the news

Blogs on High density lipoprotein

Directions to Hospitals Treating High density lipoprotein

Risk calculators and risk factors for High density lipoprotein

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]; Raviteja Guddeti, M.B.B.S. [3]

Overview

Pathophysiology

Causes

Epidemiology and Demographics

Low HDL and Cardiovascular Risk

Treatment

Landmark Trials | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Related Chapters

External Links


de:HDL (Medizin) it:Lipoproteine ad alta densità sv:Low density lipoprotein

Template:WikiDoc Sources